Ebola virus disease (EVD) (also known as Ebola hemorrhagic fever (EHF) or simply Ebola) is a viral hemorrhagic disease caused by the Ebola filovirus. Ebola is an extremely virulent virus with case fatality rates of ~70% 1.
First recognized in 1967 after polio vaccine laboratory workers were exposed to infected primates brought to Europe from Africa. The first outbreak occurred in 1976 in Zaire (since 1997 the Democratic Republic of the Cοngo), killing 318 people 2. A more recent outbreak which started in March 2014 and ended in 2016, involved multiple countries, spanning three continents and represented the largest known outbreak in history with 28,652 probable and confirmed cases, and 11,325 deaths 2.
The initial clinical syndrome is non-specific and features flu-like symptoms such as fever, myalgia, and general malaise. This is followed by nausea, vomiting, diarrhea, and rashes progressing to petechiae, conjunctival hemorrhage, epistaxis, melena, hematemesis, shock and encephalopathy 3.
The incubation period of the virus is 2-21 days.
It occurs by coming in direct contact with infected fluid like blood, breast milk, semen, saliva, sweat, feces, and vomit, through broken skin, mucous membranes or contaminated medical equipment.
Due to the fact that Ebola is predominantly a disease of resource-poor areas, little data on specific imaging features of Ebola exists. However, necropsy studies on non-human primates suggest that aerosolized virus would be unlikely to produce discrete, radiographically visible, pulmonary lesions 4.
Treatment and prognosis
Recent research has yielded not only the possibility of a vaccine 5 but also treatments for patients with Ebola. The Pamoja Tulinde Maisha/PALM trial of various treatments yielded positive results for two drugs 6. Survivors of Ebola suffer long term sequelae 7.
History and etymology
Ebola is named after a river called l’Ebola near the village where the virus was first isolated in what is now the Democratic Republic of the Congo 8.
The differential diagnosis for Ebola includes other hemorrhagic fevers such as Marburg hemorrhagic fever, Lassa fever and Crimean-Congo hemorrhagic fever.
- 1. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377 (9768): 849-62. doi:10.1016/S0140-6736(10)60667-8 - Free text at pubmed - Pubmed citation
- 2. Center for Disease Control and Prevention Outbreaks Chronology: Ebola Virus Disease
- 3. Ansari AA. Clinical features and pathobiology of Ebolavirus infection. J. Autoimmun. 2014; . doi:10.1016/j.jaut.2014.09.001 - Pubmed citation
- 4. Li K, Thomasson D, Ketai L et-al. Potential applications of conventional and molecular imaging to biodefense research. Clin. Infect. Dis. 2005;40 (10): 1471-80. doi:10.1086/429723 - Pubmed citation
- 5. Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). (2017) Lancet (London, England). 389 (10068): 505-518. doi:10.1016/S0140-6736(16)32621-6 - Pubmed
- 6. Dyer O. Two Ebola treatments halve deaths in trial in DRC outbreak. (2019) BMJ (Clinical research ed.). 366: l5140. doi:10.1136/bmj.l5140 - Pubmed
- 7. Understanding long-term effects of Ebola virus disease. (2019) Nature Medicine. 25 (5): 714. doi:10.1038/s41591-019-0444-0 - Pubmed
- 8. Etymologia. Ebola. (2015) Emerging infectious diseases. 21 (11): 1905. doi:10.3201/eid2111.et2111 - Pubmed